ATRX and astrocytoma (excluding glioblastoma): confirmed an increased prevalence of ATRX mutations among high-grade intramedullary astrocytomas compared to low-grade astrocytomas, detecting mutations in 33% of histological Grade 3 and 4 tumors, but only 13% of Grade 1 and 2 tumors (86).